Information Journal Paper
APA:
Copy. (2017). Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (The TRIDENT study). CIRCULATION RESEARCH, 121(11), 1279-1290. SID. https://sid.ir/paper/783593/en
Vancouver:
Copy. Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (The TRIDENT study). CIRCULATION RESEARCH[Internet]. 2017;121(11):1279-1290. Available from: https://sid.ir/paper/783593/en
IEEE:
Copy, “Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (The TRIDENT study),” CIRCULATION RESEARCH, vol. 121, no. 11, pp. 1279–1290, 2017, [Online]. Available: https://sid.ir/paper/783593/en